Drug shortages and price fluctuations have become the new normal for health system pharmacies. Global volatility, regulatory pressures and market compression are raising costs and threatening patient care. At the same time the Inflation Reduction Act is reshaping drug pricing with ripple effects that increase financial risk for providers.
This white paper explores how pharmacies can respond to these challenges with a smarter and more resilient procurement strategy. It details how drug shortages now last an average of 18 weeks, why outdated manual processes and vendor over-reliance create compliance risks and how staffing shortages make the problem worse.
By examining four pillars of smarter pharmacy procurement—vendor diversification, resilient workflows, data-driven inventory management and confident compliance—this paper highlights how pharmacies can turn disruption into opportunity. Case studies demonstrate how automation and integrated solutions not only reduce cost of goods sold but also preserve rebates, ensure compliance and free staff to focus on patient care.
Ultimately pharmacies that embrace technology-driven procurement strategies can mitigate the impact of shortages, anticipate rising costs and strengthen long-term resilience.
Learn how to diversify vendors without losing compliance
Reduce COGS through smarter tech-enabled procurement
Preserve rebate tiers and avoid missed incentives
Streamline procurement and inventory workflows
Improve visibility into real-time supply and pricing
Anticipate and mitigate drug shortages proactively
Enhance staff efficiency and reduce burnout
Strengthen compliance with vendor contracts and DSCSA
